Published in Anesth Analg on November 01, 1996
Characterizing preclinical models of ischemic heart failure: differences between LAD and LCx infarctions. Am J Physiol Heart Circ Physiol (2014) 1.33
Effects of isoflurane on Tei-index of myocardial performance in healthy dogs. Can Vet J (2007) 0.78
Effects of isoflurane and propofol on arterial mechanical properties. Anesth Analg (1997) 0.75
Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil. Eur Respir J (2006) 2.39
Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med (1991) 2.34
End points in pulmonary arterial hypertension: the way forward. Eur Respir J (2004) 2.21
Pulmonary hypertension in COPD. Eur Respir J (2008) 2.03
Successful treatment of acute mountain sickness with dexamethasone. Br Med J (Clin Res Ed) (1987) 1.75
Isolated right ventricular dysfunction in systemic sclerosis: latent pulmonary hypertension? Eur Respir J (2007) 1.63
Optimising the management of pulmonary arterial hypertension patients: emergency treatments. Eur Respir Rev (2010) 1.62
Long term treatment of pulmonary arterial hypertension with beraprost, an oral prostacyclin analogue. Heart (2001) 1.59
High-altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation (2001) 1.54
Uric acid, anion gap and urea concentration in the diagnostic approach to hyponatremia. Clin Nephrol (1994) 1.54
High altitude impairs nasal transepithelial sodium transport in HAPE-prone subjects. Eur Respir J (2004) 1.53
Haemodynamic evaluation of pulmonary hypertension. Eur Respir J (2002) 1.53
The hepatopulmonary syndrome: NO way out? Eur Respir J (2004) 1.49
Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by urea. Am J Med (1980) 1.44
Prostaglandin E1 infusion for right ventricular failure after cardiac transplantation. J Thorac Cardiovasc Surg (1992) 1.42
Anesthetic depth defined using multiple noxious stimuli during isoflurane/oxygen anesthesia. I. Motor reactions. Anesthesiology (1994) 1.41
Treatment of acute mountain sickness by simulated descent: a randomised controlled trial. BMJ (1993) 1.39
Brief report: reuse of a transplanted heart. N Engl J Med (1993) 1.38
Nifedipine for high altitude pulmonary oedema. Lancet (1989) 1.32
Measurement of quality of life in pulmonary hypertension and its significance. Eur Respir J (2006) 1.23
More on the noninvasive diagnosis of pulmonary hypertension: Doppler echocardiography revisited. Eur Respir J (1995) 1.22
Clinical relevance of autonomic nervous system disturbances in pulmonary arterial hypertension. Eur Respir J (2009) 1.20
End-points and clinical trial design in pulmonary arterial hypertension: have we made progress? Eur Respir J (2009) 1.18
Treatment of portal hypertension with isosorbide dinitrate alone and in combination with vasopressin. Crit Care Med (1983) 1.16
Exercise stress echocardiography for the study of the pulmonary circulation. Eur Respir J (2009) 1.15
Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension. Eur Respir J (2009) 1.11
Simulated descent v dexamethasone in treatment of acute mountain sickness: a randomised trial. BMJ (1995) 1.09
Pulmonary vascular impedance vs. resistance in hypoxic and hyperoxic dogs: effects of propofol and isoflurane. J Appl Physiol (1985) (1993) 1.07
Demeclocycline treatment of water retention in congestive heart failure. Br Med J (1978) 1.07
Comparison of carbon-dioxide-enriched, oxygen-enriched, and normal air in treatment of acute mountain sickness. Lancet (1990) 1.07
Thermodilution measurement of right ventricular ejection fraction with a modified pulmonary artery catheter. Intensive Care Med (1986) 1.06
Permissive hypercapnia impairs pulmonary gas exchange in the acute respiratory distress syndrome. Am J Respir Crit Care Med (2000) 1.05
Deleterious effect of nifedipine on pulmonary gas exchange in chronic obstructive pulmonary disease. Am Rev Respir Dis (1984) 1.04
Effects of vasodilators on hypoxic pulmonary vasoconstriction in normal man. Chest (1982) 1.04
Enhanced cerebral blood flow in acute mountain sickness. Aviat Space Environ Med (1994) 1.04
Echocardiographic and invasive measurements of pulmonary artery pressure correlate closely at high altitude. Am J Physiol Heart Circ Physiol (2000) 1.02
Enhanced fibrin formation in high-altitude pulmonary edema. J Appl Physiol (1985) (1987) 1.00
Exaggerated pulmonary hypertension is not sufficient to trigger high-altitude pulmonary oedema in humans. Schweiz Med Wochenschr (2000) 0.99
Pathobiology of pulmonary arterial hypertension. Eur Respir J (2002) 0.99
Effects of acidosis and alkalosis on hypoxic pulmonary vasoconstriction in dogs. Am J Physiol (1990) 0.97
Exercise testing in pulmonary arterial hypertension and in chronic heart failure. Eur Respir J (2004) 0.97
Effects of nifedipine on ventilation/perfusion matching in primary pulmonary hypertension. Chest (1983) 0.96
Treatment of diabetic coma with small intravenous insulin boluses. Br Med J (1976) 0.95
[Rhabdomyolysis in patients treated with simvastatin and cyclosporin: role of the hepatic cytochrome P450 enzyme system activity]. Schweiz Med Wochenschr (1995) 0.94
Pulse pressure method and the area method for the estimation of total arterial compliance in dogs: sensitivity to wave reflection intensity. Ann Biomed Eng (1999) 0.94
Improvement in ventilation-perfusion matching by almitrine in COPD. Chest (1983) 0.94
Enhanced exercise-induced rise of aldosterone and vasopressin preceding mountain sickness. J Appl Physiol (1985) (1991) 0.94
Effects of hypoxic pulmonary vasoconstriction on pulmonary gas exchange. J Appl Physiol (1985) (1996) 0.93
Single arterial occlusion to locate resistance in patients with pulmonary hypertension. Eur Respir J (2003) 0.93
Prostaglandin E1 in the adult respiratory distress syndrome. Benefit for pulmonary hypertension and cost for pulmonary gas exchange. Am Rev Respir Dis (1989) 0.93
Acute mountain sickness is not related to cerebral blood flow: a decompression chamber study. J Appl Physiol (1985) (1999) 0.91
[Aortic valve insufficiency in Crohn disease]. Schweiz Med Wochenschr (1997) 0.91
Should cardiac transplantation for congenital heart disease be delayed until adult age? Eur J Cardiothorac Surg (1994) 0.91
Partitioning of pulmonary vascular resistance in primary pulmonary hypertension. J Am Coll Cardiol (1998) 0.91
Relationship of middle cerebral artery blood flow velocity to intensity during dynamic exercise in normal subjects. Eur J Appl Physiol Occup Physiol (1993) 0.91
Physiology in medicine: importance of hypoxic pulmonary vasoconstriction in maintaining arterial oxygenation during acute respiratory failure. Crit Care (2001) 0.90
The value of tools to assess pulmonary arterial hypertension. Eur Respir Rev (2011) 0.90
Sympathetic modulation of hypoxic pulmonary vasoconstriction in intact dogs. Cardiovasc Res (1997) 0.90
Physiological response to the six-minute walk test in pulmonary arterial hypertension. Eur Respir J (2005) 0.90
Pulmonary and extrapulmonary contributors to hypoxemia in liver cirrhosis. Am Rev Respir Dis (1989) 0.90
Survival and quality of life after prolonged intensive care unit stay. Anaesth Intensive Care (2007) 0.90
Effects of high-altitude exposure on vascular endothelial growth factor levels in man. Eur J Appl Physiol (2001) 0.89
Letter: small intravenous insulin boluses in the treatment of diabetic coma. Lancet (1975) 0.88
Effects of low flow on pulmonary vascular flow-pressure curves and pulmonary vascular impedance. Cardiovasc Res (1999) 0.88
Hypoxic pulmonary vasoconstriction and pulmonary gas exchange in normal man. Respir Physiol (1987) 0.88
Pulmonary vascular responses to exercise: a haemodynamic observation. Eur Respir J (2012) 0.88
Toxoplasmosis in heart transplant recipients. Eur J Clin Microbiol Infect Dis (1996) 0.88
Patterns of alcohol consumption and acute myocardial infarction: a case-crossover analysis. Eur Addict Res (2009) 0.88
Effects of pulmonary embolism on pulmonary vascular impedance in dogs and minipigs. J Appl Physiol (1985) (1998) 0.87
Terminal events in the intensive care unit: review of 258 fatal cases in one year. Crit Care Med (1989) 0.87
Comparison of the effects of isoflurane with those of propofol on pulmonary vascular impedance in experimental embolic pulmonary hypertension. Br J Anaesth (1997) 0.87
Cognitive changes at high altitude in healthy climbers and in climbers developing acute mountain sickness. Aviat Space Environ Med (1991) 0.87
Pulmonary arterial compliance in dogs and pigs: the three-element windkessel model revisited. Am J Physiol (1999) 0.87
Effects of almitrine in decompensated chronic respiratory insufficiency. Bull Eur Physiopathol Respir (1981) 0.86
Acute pulmonary edema following carbon monoxide poisoning. Intensive Care Med (1980) 0.86
Effects of embolus size on hemodynamics and gas exchange in canine embolic pulmonary hypertension. J Appl Physiol (1985) (1990) 0.86
Outcome measures in pulmonary arterial hypertension associated with systemic sclerosis. Rheumatology (Oxford) (2008) 0.86
Orthotopic heart transplantation: an efficient treatment in a young boy with doxorubicin-induced cardiomyopathy. J Heart Lung Transplant (1992) 0.85
Expression of the serotonin 1b receptor in experimental pulmonary hypertension. Eur Respir J (2003) 0.85
Hypoxic pulmonary vasoconstriction and high altitude pulmonary edema. Am Rev Respir Dis (1986) 0.85
Platelet count and function at high altitude and in high-altitude pulmonary edema. J Appl Physiol (1985) (2006) 0.85
Pulmonary vascular tone improves pulmonary gas exchange in the adult respiratory distress syndrome. Am Rev Respir Dis (1987) 0.85
Breathing more with weaker respiratory muscles in pulmonary arterial hypertension. Eur Respir J (2005) 0.85
Is nasogastric suction necessary in acute pancreatitis? Br Med J (1978) 0.84
Septic shock without documented infection: an uncommon entity with a high mortality. Intensive Care Med (1999) 0.84
Cerebral blood flow velocity responses to hypoxia in subjects who are susceptible to high-altitude pulmonary oedema. Eur J Appl Physiol Occup Physiol (1999) 0.84